Vaxart (MEX:VXRT) E10: MXN-49.39 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:VXRT Vaxart Inc MEX:VXRT
50 GF Score
Price MXN12.00
! 3 Warning Signs
View Full Analysis

What is Vaxart E10?

Vaxart MEX:VXRT 50 E10 is MXN-49.39 as of Mar. 2026. GuruFocus rates MEX:VXRT with a GF Score™ of 50/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Vaxart's adjusted earnings per share data for the three months ended in Mar. 2026 was MXN0.361. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN-49.39 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 15.00% per year. During the past 5 years, the average E10 Growth Rate was 13.30% per year. During the past 10 years, the average E10 Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Vaxart was 58.40% per year. The lowest was -163.80% per year. And the median was 7.30% per year.

As of today (2026-08-03), Vaxart's current stock price is MXN12.00. Vaxart's E10 for the quarter that ended in Mar. 2026 was MXN-49.39. Vaxart's Shiller PE Ratio of today is .


Vaxart  (MEX:VXRT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Vaxart E10 Related Terms


Vaxart E10 Historical Data

* Premium members only.

The historical data trend for Vaxart's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxart E10 Chart

Vaxart Annual Data
Trend Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -105.85 -67.44 -87.07 -69.60 -91.80

Vaxart Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -116.46 -84.16 -96.70 -91.80 -49.39

MEX:VXRT vs VTVT, SPRB, ENGN: E10 Comparison

For the Biotechnology subindustry, Vaxart's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxart Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxart's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vaxart's Shiller PE Ratio falls into.


MEX:VXRT
50GF Score
Vaxart Inc MEX:VXRT
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxart E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vaxart's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.361/330.2130*330.2130
=0.361

Current CPI (Mar. 2026) = 330.2130.

Vaxart Quarterly Data

per share eps CPI Adj_EPS
201606 -36.617 241.018 -50.168
201609 -55.300 241.428 -75.637
201612 -54.429 241.432 -74.444
201703 -22.783 243.801 -30.858
201706 -29.825 244.955 -40.206
201709 -27.948 246.819 -37.391
201712 -19.443 246.524 -26.043
201803 8.902 249.554 11.779
201806 -24.365 251.989 -31.929
201809 -17.209 252.439 -22.511
201812 -13.548 251.233 -17.807
201903 -3.492 254.202 -4.536
201906 -7.491 256.143 -9.657
201909 -6.317 256.759 -8.124
201912 -2.452 256.974 -3.151
202003 -0.469 258.115 -0.600
202006 -2.770 257.797 -3.548
202009 -1.767 260.280 -2.242
202012 -2.586 260.474 -3.278
202103 -2.862 264.877 -3.568
202106 -2.588 271.696 -3.145
202109 -2.879 274.310 -3.466
202112 -3.487 278.802 -4.130
202203 -3.982 287.504 -4.574
202206 -4.627 296.311 -5.156
202209 -4.626 296.808 -5.147
202212 -3.509 296.797 -3.904
202303 -3.425 301.836 -3.747
202306 -2.743 305.109 -2.969
202309 -1.916 307.789 -2.056
202312 -2.037 306.746 -2.193
202403 -2.323 312.332 -2.456
202406 -1.649 314.175 -1.733
202409 -1.181 315.301 -1.237
202412 -1.043 315.605 -1.091
202503 -1.432 319.799 -1.479
202506 -1.318 322.561 -1.349
202509 -0.734 324.800 -0.746
202512 4.321 324.054 4.403
202603 0.361 330.213 0.361

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN-49.39 mean?
Vaxart (MEX:VXRT) has a E10 of MXN-49.39 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Vaxart and its competitors.
Is Vaxart's E10 too high?
Vaxart's current E10 is MXN-49.39. Overall, Vaxart has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Vaxart's E10 compare to VTVT and SPRB?
Vaxart's E10 of MXN-49.39 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Vaxart and its competitors. Vaxart's current E10 is MXN-49.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxart stock overvalued right now?
Vaxart (MEX:VXRT) has a current E10 of MXN-49.39. The current E10 is MXN-49.39. Vaxart's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Vaxart (MEX:VXRT), the current E10 is MXN-49.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vaxart Business Description

Other Exchanges VXRT:USA
Address 170 Harbor Way, Suite 300, South San Francisco, CA, USA, 94080
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically, all the business activity functions through the region of the United States.
50GF Score

Get the complete analysis for MEX:VXRT

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN12.00
Price